Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.846715
Abstract: Cancer has posed a major threat to human life and health with a rapidly increasing number of patients. The complexity and refractory of tumors have brought great challenges to tumor treatment. In recent years, nanomaterials… read more here.
Keywords: tumor treatment; therapy; therapies past; tumor therapies ... See more keywords
Dianthin and Its Potential in Targeted Tumor Therapies
Sign Up to like & getrecommendations! Published in 2019 at "Toxins"
DOI: 10.3390/toxins11100592
Abstract: Dianthin enzymes belong to ribosome-inactivating proteins (RIPs) of type 1, i.e., they only consist of a catalytic domain and do not have a cell binding moiety. Dianthin-30 is very similar to saporin-S3 and saporin-S6, two… read more here.
Keywords: targeted tumor; tumor therapies; potential targeted; dianthin potential ... See more keywords